Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Pulmonary Arterial Hypertension Children Associated With Left to Right Shunt Congenital Heart Defect

NCT03431649 is registered in ClinicalTrials.gov with Dr. Soetomo General Hospital as lead sponsor.

NCT NCT03431649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Pulmonary Arterial Hypertension Children Associated With Left to Right Shunt Congenital Heart Defect
Lead sponsor
Dr. Soetomo General Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2017
Completion date
October 30, 2017
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric pulmonary hypertension